SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-018542
Filing Date
2021-05-06
Accepted
2021-05-06 21:25:17
Documents
2
Period of Report
2021-05-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5661
2 EX-24 DOCUMENT attachment1.htm EX-24 4536
  Complete submission text file 0000899243-21-018542.txt   11556
Mailing Address 101 MAIN STREET, SUITE 1210 CAMBRIDGE MA 02142
Business Address
Requadt Scott (Reporting) CIK: 0001664852 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40384 | Film No.: 21899949

Mailing Address 201 E. JEFFERSON ST., SUITE 110B LOUISVILLE KY 40202
Business Address 201 E. JEFFERSON ST., SUITE 110B LOUISVILLE KY 40202 502-569-1059
Talaris Therapeutics, Inc. (Issuer) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)